Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | TSHR | P16473 | 2/20 | 0.58 |
| ▸ | TP53 | P04637 | 2/20 | 0.58 |
| ▸ | CA1 | P00915 | 2/20 | 0.58 |
| ▸ | CA2 | P00918 | 2/20 | 0.58 |
| ▸ | LMNA | P02545 | 4/20 | 0.53 |
| ▸ | CYP1A2 | P05177 | 3/20 | 0.53 |
| ▸ | AGTR1 | P30556 | 1/20 | 0.53 |
| ▸ | CYP3A4 | P08684 | 3/20 | 0.44 |
| ▸ | KDM4E | B2RXH2 | 3/20 | 0.43 |
| ▸ | MAPT | P10636 | 2/20 | 0.43 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.43 |
| ▸ | HPGD | P15428 | 1/20 | 0.43 |
| ▸ | ALOX15 | P16050 | 1/20 | 0.43 |
| ▸ | ALOX12 | P18054 | 1/20 | 0.43 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.43 |
| ▸ | HSD17B10 | Q99714 | 1/20 | 0.43 |
| ▸ | MMP1 | P03956 | 1/20 | 0.40 |
| ▸ | BCHE | P06276 | 1/20 | 0.39 |
| ▸ | TYR | P14679 | 1/20 | 0.39 |
| ▸ | ACHE | P22303 | 1/20 | 0.39 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Guaiacol SCHEMBL6712813 | 0.92 | TP53 (0.69) | TSHRTP53CA1CA2LMNA | |
| Guaiacol SCHEMBL10429895 | 0.90 | TSHR (0.67) | TSHRTP53CA1CA2LMNA | |
| Guaiacol SCHEMBL11198942 | 0.88 | TP53 (0.75) | TSHRTP53CA1CA2LMNA | |
| Guaiacol SCHEMBL2033828 | 0.86 | TP53 (0.67) | TSHRTP53CA1CA2LMNA | |
| Guaiacol SCHEMBL339020 | 0.85 | CYP1A2 (0.63) | TSHRTP53CA1CA2LMNA | |
| Guaiacol SCHEMBL27509885 | 0.82 | CA1 (0.86) | TSHRTP53CA1CA2LMNA | |
| Guaiacol SCHEMBL27508645 | 0.81 | CYP1A2 (0.61) | TSHRTP53CA1CA2LMNA | |
| Guaiacol SCHEMBL5323161 | 0.80 | TP53 (0.62) | TSHRTP53CA1CA2LMNA | |
| Guaiacol SCHEMBL9447670 | 0.79 | TSHR (0.47) | TSHRTP53CA1CA2LMNA | |
| Guaiacol SCHEMBL28330363 | 0.78 | CA1 (0.86) | TSHRTP53CA1CA2LMNA |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 563 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20260090584-A1 | SYSTEMS AND METHODS FOR ESTIMATING AEROSOLIZATION EMISSION | SCIENTIFIC HORIZONS CONSULTING LLC (US) | 2026-04-02 | — | — | US | claimed |
| US-12459060-B2 | Solder paste | SENJU METAL INDUSTRY CO., LTD. (JP) | 2025-11-04 | — | — | US | claimed |
| EP-4590371-A2 | SYSTEMS AND METHODS FOR ESTIMATING AEROSOLIZATION EMISSION | Scientific Horizons consulting LLC (US) | 2025-07-30 | — | — | EP | claimed |
| WO-2024064885-A2 | SYSTEMS AND METHODS FOR ESTIMATING AEROSOLIZATION EMISSION | SCIENTIFIC HORIZONS CONSULTING LLC (US) | 2024-03-28 | — | — | WO | claimed |
| CN-115778911-A | Dextromethorphan hydrobromide and guaiacol glyceryl ether compound tablet and preparation method thereof | 山西兰花药业股份有限公司 | 2023-03-14 | — | — | CN | claimed |
| US-11292089-B2 | Resin composition for soldering, resin flux cored solder, flux coated solder, and liquid flux | SENJU METAL INDUSTRY CO., LTD. (JP) | 2022-04-05 | — | — | US | claimed |
| CN-109718276-B | Compound liquorice oral solution and preparation method thereof | 上海美优制药有限公司 | 2021-09-28 | — | — | CN | claimed |
| CN-110327339-A | A kind of compound Dextromethorphan oral administration solution and its preparation method and application | 北京博达绿洲医药科技研究有限公司 | 2019-10-15 | — | — | CN | claimed |
| CN-109970606-A | A method of preparing methocarbamol | 浙江海洲制药有限公司 | 2019-07-05 | — | — | CN | claimed |
| CN-109718276-A | A kind of compound glycyrrhiza oral solution and preparation method thereof | 上海美优制药有限公司 | 2019-05-07 | — | — | CN | claimed |
| CN-101277684-A | Microparticles for the modified release of at least one active principle and oral pharmaceutical forms containing them | FLAMEL TECH SA (FR) | 2008-10-01 | — | — | CN | claimed |
| CN-1324112-C | Functionalized cubic liquid crystalline phase materials and methods for their preparation and use | PROCTER & GAMBLE CO LTD (US) | 2007-07-04 | — | — | CN | claimed |
| CN-1250719-C | Non-invasive detection of colorectal cancer and other gastrointestinal pathologies | NAIR PADMANABHAN P (US) | 2006-04-12 | — | — | CN | claimed |
| CN-1159313-C | Alkali-metal or alkali-earth metal salt of polyprotic acid delotadine and its medical composition | 何广卫 | 2004-07-28 | — | — | CN | claimed |
| CN-1397556-A | Alkali-metal or alkali-earth metal salt of polyprotic acid delotadine and its medical composition | HE GUANGWEI (CN) | 2003-02-19 | — | — | CN | claimed |
| CN-1349559-A | Non-invasive detection of colorectal cancer and other gastrointestinal pathologies | NAIR PADMANABHAN P (US) | 2002-05-15 | — | — | CN | claimed |
| US-6093805-A | AGLYCON COMPOUNDS HAVING HYDROXY, MERCAPTO, OR CARBOXY GROUP AND LINKED TO MONO- AND DISACCHARIDES HAVING 2,3-DIDEOXY-ALPHA-D-ERYTHRO-HEX-2-ENOPYRANOSIDE MOIETY; BETTER PHARMACOLOGICAL PROPERTIES INCLUDING WATER SOLUBILITY | THE REGENTS OF THE UNIVERSITY OF MICHIGAN (US) | 2000-07-25 | — | — | US | claimed |
| WO-1995032981-A1 | NOVEL GLYCOSIDE COMPOUNDS AND PRODUCTION AND USE THEREOF | HARRIER, INC. (US) | 1995-12-07 | — | — | WO | claimed |
| EP-0058987-B1 | PROCESS FOR THE PREPARATION OF GUAIACOL GLYCERYL ETHER | Degussa Aktiengesellschaft (DE) | 1985-06-12 | — | — | EP | claimed |
| US-4390732-A | Process for the production of guaiacol glycerine ether | DEGUSSA AG (DE) | 1983-06-28 | — | — | US | claimed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20260090584-A1 | SYSTEMS AND METHODS FOR ESTIMATING AEROSOLIZATION EMISSION | TMCO1, TANK, SARAF | TSHR 1046/4885TP53 1631/4885CA1 990/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.